AI is reshaping cancer research and drug discovery.

In this podcast, Dr. Peter Winter (Broad Institute of MIT and Harvard) and Dr. Barbara Engelhardt (Stanford University and Gladstone Institutes) explore how AI is helping identify drug targets, design better molecules, and accelerate the path to new treatments. They also dive into the challenges of data quality, model validation, and building collaborations between biologists and AI experts to push the field forward.